Publications by authors named "Mathias Alterman"

Claim this Profile
H
High affinity rigidified AT receptor ligands with indane scaffolds.
Charlotta Wallinder, Christian Sköld, Sara Sundholm, Marie-Odile Guimond, Samir Yahiaoui, Mathias Alterman

Medchemcomm· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive rats.
Claudia A McCarthy, Antony Vinh, Alyson A Miller, Anders Hallberg, Mathias Alterman

PLoS One· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands.
Charlotta Wallinder, Christian Sköld, Milad Botros, Marie-Odile Guimond, Mathias Hallberg, Mathias Alterman

ACS Med Chem Lett· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats.
Michaël Shum, Sandra Pinard, Marie-Odile Guimond, Sébastien M Labbé, Claude Roberge, Mathias Alterman

Am J Physiol Endocrinol Metab· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT(2)) receptor. Effects on neurite outgrowth in NG108-15 cells.
Marie-Odile Guimond, Charlotta Wallinder, Mathias Alterman, Anders Hallberg, Nicole Gallo-Payet

Eur J Pharmacol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease?
Nicole Gallo-Payet, Marie-Odile Guimond, Lyne Bilodeau, Charlotta Wallinder, Mathias Alterman

Front Endocrinol (Lausanne)· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From the first selective non-peptide AT(2) receptor agonist to structurally related antagonists.
A M S Murugaiah, Xiongyu Wu, Charlotta Wallinder, A K Mahalingam, Yiqian Wan, Mathias Alterman

J Med Chem· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A facilitated approach to evaluate the inhibitor mode and potency of compounds targeting microsomal prostaglandin e synthase-1.
Linda Spahiu, Patric Stenberg, Charlotte Larsson, Johan Wannberg, Mathias Alterman

Assay Drug Dev Technol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibition.
A K Mahalingam, Yiqian Wan, A M S Murugaiah, Charlotta Wallinder, Xiongyu Wu, Mathias Alterman

Bioorg Med Chem· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB.
Franziska Rompe, Metin Artuc, Anders Hallberg, Mathias Alterman, Katja Ströder

Hypertension· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of selective non-peptide angiotensin II type 2 receptor agonists.
Mathias Alterman

J Renin Angiotensin Aldosterone Syst· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?
Elena Kaschina, Aleksandra Grzesiak, Jun Li, Anna Foryst-Ludwig, Melanie Timm, Mathias Alterman

Circulation· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective angiotensin II AT2 receptor agonists: Benzamide structure-activity relationships.
Charlotta Wallinder, Milad Botros, Ulrika Rosenström, Marie-Odile Guimond, Hélène Beaudry, Mathias Alterman

Bioorg Med Chem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective angiotensin II AT(2) receptor agonists devoid of the imidazole ring system.
A M S Murugaiah, Chalotta Wallinder, A K Mahalingam, Xiongyu Wu, Yiqian Wan, Mathias Alterman

Bioorg Med Chem· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective angiotensin II AT2 receptor agonists: arylbenzylimidazole structure-activity relationships.
Xiongyu Wu, Yiqian Wan, A K Mahalingam, A M S Murugaiah, Bianca Plouffe, Mathias Alterman

J Med Chem· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.
Yiqian Wan, Charlotta Wallinder, Bianca Plouffe, Hélène Beaudry, A K Mahalingam, Mathias Alterman

J Med Chem· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivo.
Yiqian Wan, Charlotta Wallinder, Berndt Johansson, Mathias Holm, A K Mahalingam, Mathias Alterman

J Med Chem· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formamide as a combined ammonia synthon and carbon monoxide source in fast palladium-catalyzed aminocarbonylations of aryl halides.
Yiqian Wan, Mathias Alterman, Mats Larhed, Anders Hallberg

J Comb Chem· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of P1-P3 groups in symmetric and asymmetric HIV-1 protease inhibitors.
Hans O Andersson, Kerstin Fridborg, Seved Löwgren, Mathias Alterman, Anna Mühlman

Eur J Biochem· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dimethylformamide as a carbon monoxide source in fast palladium-catalyzed aminocarbonylations of aryl bromides.
Yiqian Wan, Mathias Alterman, Mats Larhed, Anders Hallberg

J Org Chem· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis